Zydelig(Idelalisib) Side Effects

Zydelig is associated with a high incidence of serious and potentially fatal adverse reactions affecting multiple organ systems.

Adverse Reaction Profile and Risk Management for Zydelig

The most common adverse reactions to Zydelig include diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, and rash. Laboratory abnormalities frequently observed are neutropenia, hypertriglyceridemia, hyperglycemia, and elevated liver enzymes (ALT, AST). 

Serious risks include hepatotoxicity, severe diarrhea/colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, and neutropenia. These toxicities may necessitate dose interruption, reduction, or permanent discontinuation. The safety profile in pediatric patients or those with significant hepatic impairment is not specified in the description.

Idelalisib(Zydelig)
Indicated for adults with relapsed chronic lymphocytic leukemia (CLL).
RELATED ARTICLES
Efficacy of Idelalisib(Zydelig) in Relapsed Chronic Lymphocytic Leukemia

Idelalisib(Zydelig) is an oral drug targeting PI3Kδ kinase that provides an important second-line treatment...

Tuesday, July 1st, 2025, 16:31
/ 1
1 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved